WO2017146657A2 - Antimicrobial benzoic acid dental gypsum composition enhanced with addition of low concentration of ipbc - Google Patents
Antimicrobial benzoic acid dental gypsum composition enhanced with addition of low concentration of ipbc Download PDFInfo
- Publication number
- WO2017146657A2 WO2017146657A2 PCT/TH2017/000013 TH2017000013W WO2017146657A2 WO 2017146657 A2 WO2017146657 A2 WO 2017146657A2 TH 2017000013 W TH2017000013 W TH 2017000013W WO 2017146657 A2 WO2017146657 A2 WO 2017146657A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- composition
- antimicrobial
- gypsum
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C13/00—Dental prostheses; Making same
- A61C13/34—Making or working of models, e.g. preliminary castings, trial dentures; Dowel pins [4]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C13/00—Dental prostheses; Making same
- A61C13/20—Methods or devices for soldering, casting, moulding or melting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/849—Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
- A61K6/858—Calcium sulfates, e.g, gypsum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/90—Compositions for taking dental impressions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
Definitions
- the present disclosure relates to the mixture of antimicrobial into a dental gypsum composition to reduce the risk of patient cross-contamination from dental gypsum models. More particularly, the present disclosure relates to the enhancement of the antimicrobial properties of benzoic acid and/or benzoic derivatives with the addition of low concentrations of IPBC into the dental gypsum composition.
- dental gypsum product lA-01 has at least two types: soft gypsum lA-02a; and hard gypsum lA-02b.
- Soft gypsum lA-02a has at least two types: type 1 for impressions lA-03a; and type 2 for models and used in orthodontics lA-03b.
- Hard gypsum lA-02b has at least two types: dental stone lA-04a; and special gypsum lA-04b.
- dental stone 1 A-04a has at least four types: type 3 used for impressions and models which has a medium strength lA-05a; type 3 used for models in orthodontics lA-05b; type 4 used for impressions which has high strength and low expansion lA-05c; and type 5 used for impressions which has high strength and high expansion lA-05d.
- type 3 used for impressions and models which has a medium strength lA-05a As shown in the second block diagram lB-00 of FIG. IB, dental stone 1 A-04a has at least four types: type 3 used for impressions and models which has a medium strength lA-05a; type 3 used for models in orthodontics lA-05b; type 4 used for impressions which has high strength and low expansion lA-05c; and type 5 used for impressions which has high strength and high expansion lA-05d.
- These dental gypsum types are generally sold as calcined gypsum and made into models per the below method.
- FIGs. 2A-2D The general method for making a dental gypsum model is pictured in FIGs. 2A-2D.
- a first pictured step 2A-00 is pouring a slurry 2A-01 (prepared in a separate step from a mixture of dental gypsum and water) into an impression 2A-02 (prepared in separate step from the teeth of a patient).
- a second pictured step 2B- 00 is setting the slurry 2A-01 in the impression 2A-02 to form the model 2B-01.
- a third pictured step 2C-00 is removing the model 2B-01 (once the model 2B-01 has set) from the impression 2A-02.
- FIG. 2A a first pictured step 2A-00 is pouring a slurry 2A-01 (prepared in a separate step from a mixture of dental gypsum and water) into an impression 2A-02 (prepared in separate step from the teeth of a patient).
- a second pictured step 2B- 00 is setting
- a fourth pictured step 2D-00 is pictures the pairing of the model 2B-01 (the lower teeth) with its separately prepared associated model 2D-01 (upper teeth).
- the models can be dipped in an antimicrobial or alternatively the dental models can incorporate an antimicrobial mixed into the dental gypsum composition, where the antimicrobial is mixed with the calcined gypsum prior to or during the preparation of the gypsum slurry.
- Benzoic acid and/or a benzoic derivative can be used as the antimicrobial in the dental gypsum composition.
- the antimicrobial can include IPBC.
- Benzoic acid is a colorless crystalline solid and a simple aromatic carboxylic acid. Benzoic acid occurs naturally in many plants. Salts of benzoic acid and benzoic acid are used as food preservatives and/or as a general antimicrobial. Derivatives of benzoic acid can include salts and esters of benzoic acid and are known as benzoates. Example benzoic derivatives include sodium benzoate, potassium benzoate, calcium benzoate and/or other benzoate salts or esters.
- IPBC is a water-soluble preservative used globally in the paints, coatings, wood preservatives, personal care, and cosmetics industries. IPBC is a powerful antimicrobial. As used in this disclosure, IPBC is meant to include: (a) the IUPAC named IPBC of 3-Iodoprop-2-yn-l-yl butylcarbamate; (b) 3-Iodo-2-propynyl N-butylcarbamate; (c) 3-Iodo-2-propynyl butylcarbamate; (d) the antimicrobial sold under the trademark Iodocarb®; and/or (e) iodopropynyl butyl carbamate. While IPBC is a cosmetic grade chemical and thus mostly non- toxic, IPBC is not a food grade chemical.
- IPBC antimicrobial mixed into the dental gypsum composition
- Thailand patent application number 1401001430 "Antimicrobial Dental Plaster Formulation and Dental Cast Thereof," filed 18 March 2014.
- the efficacy of IPBC increases as the percentage of IPBC increases from 0.001% to 0.01 % by weight of the composition.
- a primary embodiment of the invention is a composition for an antimicrobial dental gypsum comprising: (a) a calcined gypsum; (b) an additive; (c) an antimicrobial agent comprising a benzoic acid and/or a benzoic derivative; and (d) an antimicrobial enhancing substance comprising IPBC.
- the antimicrobial agent is in the range of 0.001 to 0.02% by weight of the composition.
- the antimicrobial enhancing substance is in the range of 0.0001 to 0.01% by weight of the composition.
- the benzoic derivative can be sodium benzoate, potassium benzoate and/or calcium benzoate.
- the additive can be a thickener, a retardant, an accelerator, a defoamer, a pigment, a stabilizer and/or a dye, wherein the additive is in the range of 2.5 to 3.5 percent by weight of the composition.
- the antimicrobial enhancing substance can further comprise citric acid, propionic acid, tartaric acid, acetic acid, oxalic acid, malic acid, salicylic acid, lactic acid, gluconic acid, hydroxyacetic acid and/or methylisothiazolinone.
- the calcined gypsum can be natural gypsum and/or synthetic gypsum.
- a second embodiment of the invention is an antimicrobial dental gypsum model comprising: (a) gypsum; (b) an additive; (c) an antimicrobial agent comprising a benzoic acid and/or a benzoic derivative; and (d) an antimicrobial enhancing substance comprising iodopropynyl butyl carbamate (IPBC).
- the antimicrobial agent is in the range of 0.001 to 0.02% by weight of the composition.
- the antimicrobial enhancing substance is in the range of 0.0001 to 0.01% by weight of the composition.
- the benzoic derivative can be sodium benzoate, potassium benzoate and/or calcium benzoate.
- the additive can be a thickener, a retardant, an accelerator, a defoamer, a pigment, a stabilizer and/or a dye, wherein the additive is in the range of 2.5 to 3.5 percent by weight of the composition.
- the antimicrobial enhancing substance can further comprise citric acid, propionic acid, tartaric acid, acetic acid, oxalic acid, malic acid, salicylic acid, lactic acid, gluconic acid, hydroxyacetic acid and/or methylisothiazolinone.
- the gypsum can be natural gypsum and/or synthetic gypsum.
- a third embodiment of the invention is a method for preparing an antimicrobial dental gypsum model, the steps comprising: (a) preparing a dental impression from the teeth of a patient; (b) preparing a composition for an antimicrobial dental gypsum to create a slurry; (c) mixing the composition and water to create a slurry; (d) pouring the slurry into the dental impression; (e) setting the slurry to form the model; and (f) removing the model from the dental impression.
- the composition in this third embodiment comprises: (1) a calcined gypsum; (2) an additive; (3) an antimicrobial agent comprising a benzoic acid and/or a benzoic derivative; and (4) an antimicrobial enhancing substance comprising iodopropynyl butyl carbamate (IPBC).
- the antimicrobial agent in this third embodiment is in the range of 0.001 to 0.02% by weight of the composition.
- the antimicrobial enhancing substance in this third embodiment is in the range of 0.0001 to 0.01% by weight of the composition.
- the ratio of the water to the composition is in the range of 30:70 to 20:80 by weight.
- the step of mixing can be performed for 1 to 3 minutes.
- the step of preparing the composition can include agitating the composition for at least 50 minutes.
- the benzoic derivative can be sodium benzoate, potassium benzoate and/or calcium benzoate.
- the additive can be a thickener, a retardant, an accelerator, a defoamer, a pigment, a stabilizer and/or a dye, wherein the additive is in the range of 2.5 to 3.5 percent by weight of the composition.
- the antimicrobial enhancing substance can further comprise citric acid, propionic acid, tartaric acid, acetic acid, oxalic acid, malic acid, salicylic acid, lactic acid, gluconic acid, hydroxyacetic acid and/or methylisothiazolinone.
- the calcined gypsum can be natural gypsum and/or synthetic gypsum.
- FIGs. 1A-1B are block diagrams of the types of dental gypsum product of the prior art.
- FIG. 2A-2D are a pictoral representation of steps taken to prepare a model of the prior art.
- FIG. 3 is a flowchart of the steps to prepare a dental gypsum model of an embodiment of the invention. DETAILED DESCRIPTION
- IPBC is a cosmetic grade chemical and thus mostly non-toxic, IPBC is not a food grade chemical.
- IPBC is safe to include in cosmetics on the outside skin of a person but IPBC is not as safe for eating.
- the model does not directly contact mucous membranes in the mouth such as the gum line, tonsils, palate and tongue.
- the models are used for fabrication of custom trays, fabrication of dentures, crowns, prosthesis and orthodontics, and these items can be contaminated with trace amounts of IPBC from the dental gypsum of models.
- a lowered concentration of IPBC in the models can reduce potential risks for oral toxicity.
- Another reason to reduce the concentration of IPBC is its relatively high cost per kilogram in comparison to other antimicrobials and calcined gypsum.
- the efficacy of IPBC increases as the percentage of IPBC increases.
- a dental gypsum composition with enhanced antimicrobial efficacy despite a low concentration of IPBC.
- FIG. 3 is a flowchart 3-00 of the steps to prepare a dental gypsum model of an embodiment of the invention.
- the flowchart 3-00 includes the steps to:
- 3-01 Prepare a dental impression from the teeth of a patient.
- the inventive step in this flowchart 3-00 of the steps to prepare a dental gypsum model is the preparation of the composition for the antimicrobial dental gypsum 3-02.
- Other steps of the flowchart are well known steps in the preparation of a model using dental gypsum.
- the below text includes a description of the composition for the antimicrobial dental gypsum and the supporting experimental results demonstrating enhanced antimicrobial properties in the usage of the invention.
- the primary embodiment of the invention is the composition for an antimicrobial dental gypsum comprising: (a) a calcined gypsum; (b) an additive; (c) an antimicrobial agent comprising a benzoic acid and/or a benzoic derivative; and (d) an antimicrobial enhancing substance comprising iodopropynyl butyl carbamate (IPBC).
- the antimicrobial agent is in the range of 0.001 to 0.02% by weight of the composition.
- the antimicrobial enhancing substance is in the range of 0.0001 to 0.01% by weight of the composition.
- the benzoic derivative can be sodium benzoate, potassium benzoate and/or calcium benzoate.
- the additive can be a thickener, a retardant, an accelerator, a defoamer, a pigment, a stabilizer and/or a dye, wherein the additive is in the range of 2.5 to 3.5 percent by weight of the composition.
- the antimicrobial enhancing substance can further comprise citric acid, propionic acid, tartaric acid, acetic acid, oxalic acid, malic acid, salicylic acid, lactic acid, gluconic acid, hydroxyacetic acid and/or methylisothiazolinone.
- the calcined gypsum can be natural gypsum and/or synthetic gypsum.
- a second embodiment of the invention is an antimicrobial dental gypsum model comprising: (a) gypsum; (b) an additive; (c) an antimicrobial agent comprising a benzoic acid and/or a benzoic derivative; and (d) an antimicrobial enhancing substance comprising IPBC.
- the antimicrobial agent is in the range of 0.001 to 0.02% by weight of the composition.
- the antimicrobial enhancing substance is in the range of 0.0001 to 0.01% by weight of the composition.
- the benzoic derivative can be sodium benzoate, potassium benzoate and/or calcium benzoate.
- the additive can be a thickener, a retardant, an accelerator, a defoamer, a pigment, a stabilizer and/or a dye, wherein the additive is in the range of 2.5 to 3.5 percent by weight of the composition.
- the antimicrobial enhancing substance can further comprise citric acid, propionic acid, tartaric acid, acetic acid, oxalic acid, malic acid, salicylic acid, lactic acid, gluconic acid, hydroxyacetic acid and/or methylisothiazolinone.
- the gypsum can be natural gypsum and/or synthetic gypsum.
- a third embodiment of the invention is a method for preparing an antimicrobial dental gypsum model, the steps comprising: (a) preparing a dental impression from the teeth of a patient; (b) preparing a composition for an antimicrobial dental gypsum to create a slurry; (c) mixing the composition and water to create a slurry; (d) pouring the slurry into the dental impression; (e) setting the slurry to form the model; and (f) removing the model from the dental impression.
- the composition in this third embodiment comprises: (1) a calcined gypsum; (2) an additive; (3) an antimicrobial agent comprising a benzoic acid and/or a benzoic derivative; and (4) an antimicrobial enhancing substance comprising IPBC.
- the antimicrobial agent in this third embodiment is in the range of 0.001 to 0.02% by weight of the composition.
- the antimicrobial enhancing substance in this third embodiment is in the range of 0.0001 to 0.01 % by weight of the composition.
- the ratio of the water to the composition is in the range of 30:70 to 20:80 by weight.
- the step of mixing can be performed for 1 to 3 minutes.
- the step of preparing the composition can include agitating the composition for at least 50 minutes.
- the benzoic derivative can be sodium benzoate, potassium benzoate and/or calcium benzoate.
- the additive can be a thickener, a retardant, an accelerator, a defoamer, a pigment, a stabilizer and/or a dye, wherein the additive is in the range of 2.5 to 3.5 percent by weight of the composition.
- the antimicrobial enhancing substance can further comprise citric acid, propionic acid, tartaric acid, acetic acid, oxalic acid, malic acid, salicylic acid, lactic acid, gluconic acid, hydroxyacetic acid and/or methylisothiazolinone.
- the calcined gypsum can be natural gypsum and/or synthetic gypsum.
- the efficacy of the enhanced antimicrobial dental gypsum is demonstrated in the below example preparations of dental gypsum models.
- the embodiments described in this specification and claims can be used to limit cross-contamination in dental clinics, hospitals and laboratories of streptococcus aureus, Candida albican and pseudomonas aeruginosa.
- Example 1 Composition for Dental Gypsum (Ex-1)
- composition of dental gypsum without antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 4.
- the composition is mixed with water (approximately 80:20 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 2 Composition for Dental Gypsum (Ex-2)
- composition of dental gypsum without antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives in the mixer.
- the mixture is stirred for 60 minutes until all components are well dispersed and homogeneous to obtain dental gypsum Type 3.
- the composition is mixed with water (approximately 70:30 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 3 Composition for Dental Gypsum (Ex-3)
- composition of dental gypsum with 0.001% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.001% of sodium benzoate in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 4.
- the composition is mixed with water (approximately 80:20 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 4 Composition for Dental Gypsum (Ex-4)
- composition of dental gypsum with 0.005% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.005% of sodium benzoate in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 4.
- the composition is mixed with water (approximately 80:20 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 5 Composition for Dental Gypsum (Ex-5)
- composition of dental gypsum with 0.01% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.01% of sodium benzoate in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 4.
- the composition is mixed with water (approximately 80:20 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 6 Composition for Dental Gypsum (Ex-6)
- composition of dental gypsum with 0.01% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.01% of IPBC in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 4.
- the composition is mixed with water (approximately 80:20 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 7 Composition for Dental Gypsum (Ex-7)
- composition of dental gypsum with 0.001% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.001% of sodium benzoate in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 3.
- the composition is mixed with water (approximately 70:30 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 8 Composition for Dental Gypsum (Ex-8)
- composition of dental gypsum with 0.005% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.005% of sodium benzoate in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 3.
- the composition is mixed with water (approximately 70:30 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 9 Composition for Dental Gypsum (Ex-9)
- composition of dental gypsum with 0.01% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.01% of sodium benzoate in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 3.
- the composition is mixed with water (approximately 70:30 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 10 Composition for Dental Gypsum (Ex-10)
- composition of dental gypsum with 0.01% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.01% of IPBC in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 3.
- the composition is mixed with water (approximately 70:30 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 11 Composition for Dental Gypsum (Ex-lf)
- composition of dental gypsum with 0.51% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.51% of sodium benzoate in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 3.
- the composition is mixed with water (approximately 70:30 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 12 Composition for Dental Gypsum (Ex-12)
- composition of dental gypsum with 0.51% of antimicrobial agent is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.51 % of IPBC in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 3.
- the composition is mixed with water (approximately 70:30 by weight) then the slurry is stirred for 1 to 3 minutes.
- Example 13 Composition for Dental Gypsum (Ex-13)
- composition of dental gypsum with 0.01% of antimicrobial agents is produced as follows.
- the composition is produced from 97% of natural gypsum by weight of the composition mixed with 3% by weight of additives and 0.0091% of sodium benzoate and 0.0009% of IPBC in the mixer.
- the mixture is stirred for 60 minutes until all the components are well dispersed and homogeneous to obtain dental gypsum Type 3.
- the composition is mixed with water (approximately 70:30 by weight) then the slurry is stirred for 1 to 3 minutes.
- microorganisms ⁇ staphylococcus aureus ATCC 6538, pseudomonas aeruginosa ATCC 27853 and Candida albicans ATCC 10231) were used.
- the microorganisms are grown on Brain Heart Infusion (BHI) agar (BBL, USA). Colonies are subcultured in BHI broth and incubated at 37 °C for 24 h.
- Microbial suspensions are prepared at the concentration of 108 CFU/mL using 0.5 MacFarland Standard. The testing process is done as follows. One hundred i of each microbial suspension is dropped on irreversible hydrocolloid impression (such as with caulk sold under the trademark Jeltrate®) and left dry for 10 min.
- Gypsum mix with different concentrations of IPBC are prepared and poured onto the impressions and allowed to set for 60 minutes. Then the gypsum mass samples are removed and the microbial contact surfaces are imprinted on BHI agar plates. The plates are incubated at 37 °C for 24 to48 hours. Colonies appearing on the agar are gram-stained and counted. Dental gypsum without antimicrobial is used as the control. All experiments are done in triplicate on three separate occasions.
- the gypsum is mixed and poured into mold (20+0.2 mm in diameter and 40+0.4 mm in length) to fabricate dental gypsum model.
- the dental gypsum models are stored in conditions mentioned above.
- models were stressed in the compressive mode until fractured using testing machine sold under the trademark Instron® with a cross-head speed of 5+2 kN/min.
- the antimicrobial efficacy of sodium benzoate can be enhanced with the addition of small concentrations of IPBC.
- Additional enhancing substances that can be included in the composition with IPBC can include citric acid, propionic acid, tartaric acid, acetic acid, oxalic acid, malic acid, salicylic acid, lactic acid, gluconic acid, hydroxyacetic acid and/or methylisothiazolinone.
- Thailand patent application number 1601001009 "Antimicrobial Dental Plaster Formulation with Benzoic Acid or Compound as Antimicrobial Agent and Dental Cast Thereof," filed 25 February 2016.
- EP1787627A1 Anti-microbial dental impression material
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dentistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Inorganic Chemistry (AREA)
- Dental Preparations (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020187026734A KR102004111B1 (en) | 2016-02-25 | 2017-02-23 | Antibiotic enhanced benzoic acid dental gypsum composition enhanced by addition of low concentration of IPBC |
| EP17756937.3A EP3419555A4 (en) | 2016-02-25 | 2017-02-23 | ANTI-MICROBIAL BENZOIC ACID DENTAL PLASTER COMPOSITION ENHANCED BY THE ADDITION OF A LOW CONCENTRATION OF IPBC |
| JP2018541204A JP2019510538A (en) | 2016-02-25 | 2017-02-23 | Antibacterial benzoic acid dental gypsum composition enhanced with the addition of low concentrations of IPBC |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TH1601001009 | 2016-02-25 | ||
| TH1601001009A TH171373A (en) | 2016-02-25 | Dental mortar formulation prevents microorganisms containing benzoic acid or its compounds. It is an antimicrobial agent and a dental casting piece from the formula. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2017146657A2 true WO2017146657A2 (en) | 2017-08-31 |
| WO2017146657A3 WO2017146657A3 (en) | 2017-10-05 |
Family
ID=59686480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/TH2017/000013 Ceased WO2017146657A2 (en) | 2016-02-25 | 2017-02-23 | Antimicrobial benzoic acid dental gypsum composition enhanced with addition of low concentration of ipbc |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3419555A4 (en) |
| JP (1) | JP2019510538A (en) |
| KR (1) | KR102004111B1 (en) |
| WO (1) | WO2017146657A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102527318B1 (en) * | 2020-10-16 | 2023-04-27 | 육근세 | Antibacterial and antifungal functional α-type hemihydrate gypsum using purified sulfuric acid and the process of manufacture thereof |
| KR102730644B1 (en) * | 2022-07-05 | 2024-11-15 | 강원대학교산학협력단 | Composition for mouthwash comprising SAEW and sodium benzoate |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2515161B2 (en) * | 1988-11-24 | 1996-07-10 | 株式会社ジーシーデンタルプロダクツ | Dental gypsum composition |
| JP2004524321A (en) * | 2001-03-01 | 2004-08-12 | ロンザ インコーポレイテッド | Combination method of iodopropynyl derivative and ketone acid or salt thereof and / or aromatic carboxylic acid or salt thereof |
| CA2487075C (en) * | 2002-06-07 | 2010-08-17 | Microban Products Company | Antimicrobial wallboard |
| KR100785232B1 (en) * | 2006-06-15 | 2007-12-11 | 남두석 | Dental antibacterial gypsum composition and its manufacturing method |
| EP2164452B1 (en) * | 2007-06-19 | 2017-03-22 | Cognis IP Management GmbH | Hydrocarbon mixture and use thereof |
| CN105165823A (en) * | 2007-10-02 | 2015-12-23 | 英默里斯筛选矿物公司 | Enhanced Retention Capabilities Through Methods Comprising Surface Treatment Of Functional Particulate Carrier Materials, And Functional Particulate Carrier Materials Made Therefrom |
-
2017
- 2017-02-23 WO PCT/TH2017/000013 patent/WO2017146657A2/en not_active Ceased
- 2017-02-23 KR KR1020187026734A patent/KR102004111B1/en not_active Expired - Fee Related
- 2017-02-23 JP JP2018541204A patent/JP2019510538A/en not_active Withdrawn
- 2017-02-23 EP EP17756937.3A patent/EP3419555A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20180115291A (en) | 2018-10-22 |
| WO2017146657A3 (en) | 2017-10-05 |
| EP3419555A4 (en) | 2019-10-23 |
| EP3419555A2 (en) | 2019-01-02 |
| JP2019510538A (en) | 2019-04-18 |
| KR102004111B1 (en) | 2019-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2924095C2 (en) | ||
| JP2020055839A (en) | Bismuth-thiol as a disinfectant for agricultural, industrial and other uses | |
| DE2822671C2 (en) | Pharmaceutical preparations for use in dentistry | |
| Zheng et al. | A liquid crystalline precursor incorporating chlorhexidine acetate and silver nanoparticles for root canal disinfection | |
| FR2882555B1 (en) | CRYSTALLINE GAMMA FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| BRPI0508579A (en) | compound, pharmaceutical composition, and use of a compound | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| FR2882556B1 (en) | CRYSTALLINE GAMMA D FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| WO2017146657A2 (en) | Antimicrobial benzoic acid dental gypsum composition enhanced with addition of low concentration of ipbc | |
| MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| WO2009009814A2 (en) | Dental material | |
| DE60310605D1 (en) | NANOTE PARTICLES FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES, METHOD FOR THE PRODUCTION OF THESE PARTICLES, AND COMPOSITIONS COMPRISING THEM | |
| DE69931541T2 (en) | Calcium phosphate cement | |
| WO2013067207A2 (en) | An improved dental material and method | |
| DE2937964A1 (en) | Agents for controlling caries - contg. antibacterial enzymes, e.g. lysozyme or dextranase, in immobilised form to prevent dilution by saliva | |
| WO2008000466A2 (en) | Use of an antimicrobial hardening alginate material for the topical treatment of wounds and inflammations in human, dental, and veterinary medicine and for cosmetic purposes | |
| Philip et al. | Current trends in reducing microbial adhesion to acrylic denture base resins. | |
| JP2025042760A (en) | Bactericide for penetrating deep into plaque layers | |
| Thaweboon et al. | Antimicrobial activity of type III dental gypsum incorporated with 3-iodo-2-propynyl-butylcarbamate and its physical properties | |
| EP3574887A1 (en) | Astringent aluminum-free retraction paste for professional dental use | |
| DE19743622C2 (en) | Dental underfill material | |
| HRP20030057A2 (en) | Antiseptic for wounds and mucous membranes | |
| Thaweboon et al. | Type IV dental stone incorporated with antimicrobial agents and its physical properties | |
| JPH11286448A (en) | Composition containing minocycline | |
| KR100785232B1 (en) | Dental antibacterial gypsum composition and its manufacturing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENP | Entry into the national phase |
Ref document number: 2018541204 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17756937 Country of ref document: EP Kind code of ref document: A2 |
|
| ENP | Entry into the national phase |
Ref document number: 20187026734 Country of ref document: KR Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1020187026734 Country of ref document: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2017756937 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2017756937 Country of ref document: EP Effective date: 20180925 |